Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beam Therapeutics, Inc.

18.10
+1.106.44%
Volume:2.40M
Turnover:44.42M
Market Cap:1.76B
PE:-3.95
High:19.48
Open:16.78
Low:16.66
Close:17.00
Loading ...

Beam Therapeutics Inc.'s (NASDAQ:BEAM) recent 11% pullback adds to one-year year losses, institutional owners may take drastic measures

Simply Wall St.
·
11 Apr

AI Biotech Stocks Shined. Recursion Soared 20% And Absci Surged 13%

Tiger Newspress
·
11 Apr

Beam Therapeutics (BEAM) Moves 12.6% Higher: Will This Strength Last?

Zacks
·
10 Apr

Beam Therapeutics Presents Biomarker Data For BEAM-302 Gene Therapy For Inherited Disease

Benzinga
·
07 Apr

Beam Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Dow Jones
·
07 Apr

Beam Therapeutics (BEAM) Gets a Buy from Scotiabank

TIPRANKS
·
07 Apr

Beam Therapeutics presents additional data for BEAM-302 in AATD

TIPRANKS
·
06 Apr

Cathie Wood’s ARK Investment buys 143K shares of Beam Therapeutics today

TIPRANKS
·
05 Apr

Cathie Wood Just Made A Bold Move—Why She Spent Over $65M On Tesla, Robinhood, And Coinbase 'As The Market Crashed'

Benzinga
·
05 Apr

When Emergencies Strike Local Broadband Providers Deliver a Communications Lifeline for Their Communities With Calix SmartTown

Business Wire
·
04 Apr

Is Beam Therapeutics Inc. (BEAM) the Best Gene-Editing Stock to Buy?

Insider Monkey
·
02 Apr

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks
·
01 Apr

Shares of Gene Therapy Makers and Developers Fall After Report That FDA Official Peter Marks Has Resigned

THOMSON REUTERS
·
31 Mar

Solid Biosciences Down 10.5%, Taysha Gene Therapies Down 14%

THOMSON REUTERS
·
31 Mar

BUZZ-Gene therapy makers slide on reports that FDA official Peter Marks resigns

Reuters
·
31 Mar

BUZZ-U.S. STOCKS ON THE MOVE-GameStop, Oxford Industries, Wolfspeed

Reuters
·
29 Mar

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Zacks
·
28 Mar

BEAM's IND for BEAM-302 in Genetic Disorder Study Gets FDA Clearance

Zacks
·
28 Mar

BUZZ-Beam Therapeutics rises after FDA clears genetic disorder drug application

Reuters
·
28 Mar

Top Calls on Wall Street: Netflix, Tesla, Nike, Meta, Disney, Lululemon & More

Tiger Newspress
·
28 Mar